The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine
- Status
- COMPLETED
- Phase
- PHASE2
A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults
- Status
- COMPLETED
- Phase
- PHASE4
Nudging Flu Vaccination in Patients at Moderately High Risk for Flu and Flu-related Complications
- Status
- COMPLETED
- Phase
- NA
Flu Shot Pre-visit Questionnaire
- Status
- COMPLETED
- Phase
- NA
Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile
- Status
- UNKNOWN
- Phase
- PHASE3
Nudging Flu Vaccination by Making it Easy for Patients to Schedule a Flu Shot
- Status
- COMPLETED
- Phase
- NA
High-risk Influenza Vaccine Alert
- Status
- COMPLETED
- Phase
- NA
To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection
- Status
- COMPLETED
- Phase
- PHASE3
Influenza IMPRINT Cohort: Defining the Impact of Initial Influenza Exposure on Immunity in Infants
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra Inj.) in Subjects Aged 3 Years Old and Above
- Status
- COMPLETED
- Phase
- N/A
To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 Years
- Status
- UNKNOWN
- Phase
- PHASE4
A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Extracorporeal Membrane Oxygenation in Coronavirus Disease (COVID-19), Influenza and ARDS of Other Ethiologies
- Status
- COMPLETED
- Phase
- N/A
Influenza Human Challenge Model
- Status
- RECRUITING
- Phase
- PHASE1
The Objectives of This Study Are Comparative Assessment of the Tolerability, Safety and Immunogenicity of the Flu-M Vaccine vs. the Ultrix® Vaccine by Single Vaccination of Children Aged 6 to 17 Years.
- Status
- COMPLETED
- Phase
- PHASE3
Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive Children
- Status
- UNKNOWN
- Phase
- NA
A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years
- Status
- COMPLETED
- Phase
- PHASE4
Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years
- Status
- COMPLETED
- Phase
- PHASE3
Tolerability, Safety and Immunogenicity Trial of the FLU-M® Tetra
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3